Current MS management rests on crude estimates of physical disability and overemphasizes identifying relapses and new MRI ...

Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new ...

Doctors at Jewish Hospital Mercy Health are pioneering a new approach to treating multiple sclerosis (MS), offering hope to ...

New data suggest the frequency of damage and repair processes correlates with disease severity and disability in multiple ...

Multiple sclerosis (MS) is a debilitating disease of the brain and spinal cord that impacts millions worldwide.

“This approach represents a novel strategy in MS treatment, and our aim is to pioneer the discovery and development of new ...

Fexagratinib targets FGF, CSF, and VEGF pathways, showing potential in MS treatment by reducing inflammation and promoting ..

Biogen expects annual adjusted profit per share of $16.10 to $16.60, compared with a $15.75 to $16.25 per-share range ...

Sir Chris Hoy and his wife Lady Sarra Hoy have discussed his terminal cancer diagnosis and given a treatment update in their ...

Ms Mallett added the building is set to undergo a major transformation which will be different from the styling at all of the current premises. "We are going to be offering a lot more new treatments ...